PUBLISHER: The Business Research Company | PRODUCT CODE: 1945403
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945403
Intracranial hemorrhage devices are medical tools designed for diagnosing, managing, and treating intracranial hemorrhages (ICH), which are bleeding events within the skull. These devices are essential for addressing conditions such as subdural hematoma, epidural hematoma, subarachnoid hemorrhage, and intracerebral hemorrhage.
The primary product categories for intracranial hemorrhage devices include diagnostic and treatment devices. Intracranial hemorrhage diagnosis refers to the process of detecting bleeding within the skull, utilizing both invasive and non-invasive devices. These devices serve various end users, such as hospitals, ambulatory surgical centers, and other healthcare facilities.
Tariffs are impacting the intracranial hemorrhage devices market by increasing costs of imported imaging systems, monitoring sensors, surgical instruments, and electronic components used in diagnostic and treatment devices. Hospitals in North America and Europe are most affected due to reliance on advanced imported imaging and monitoring equipment, while Asia-Pacific faces higher capital expenditure for device procurement. These tariffs are raising treatment costs and delaying equipment upgrades. However, they are also encouraging domestic manufacturing, localized assembly, and investment in regional neurodevice development capabilities.
The intracranial hemorrhage devices market research report is one of a series of new reports from The Business Research Company that provides intracranial hemorrhage devices market statistics, including intracranial hemorrhage devices industry global market size, regional shares, competitors with a intracranial hemorrhage devices market share, detailed intracranial hemorrhage devices market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial hemorrhage devices industry. This intracranial hemorrhage devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intracranial hemorrhage devices market size has grown strongly in recent years. It will grow from $1.79 billion in 2025 to $1.88 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing incidence of traumatic brain injuries, rising prevalence of stroke cases, expansion of neurocritical care units, growth in emergency medical services, availability of advanced diagnostic devices.
The intracranial hemorrhage devices market size is expected to see steady growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing investments in neurotechnology, rising demand for real-time brain monitoring, expansion of minimally invasive neurosurgery, growing adoption of AI-assisted imaging analysis, increasing focus on early intervention protocols. Major trends in the forecast period include increasing use of advanced neuroimaging devices, rising adoption of minimally invasive treatment solutions, growing integration of intracranial pressure monitoring, expansion of emergency stroke and trauma care, enhanced focus on rapid diagnosis and intervention.
The rising cases of brain disorders are expected to propel the growth of the intracranial hemorrhage devices market going forward. Brain disorders refer to a wide range of conditions that affect the structure, function, or chemistry of the brain, leading to disruptions in normal brain processes. The cases of brain disorders are increasing due to factors such as improved diagnostics, aging populations, lifestyle changes, and greater awareness, along with rising stress. Intracranial hemorrhage devices are used to detect, monitor, and treat brain disorders involving bleeding by identifying hemorrhages, managing pressure, and removing blood clots to prevent further brain damage. For instance, in October 2025, according to the World Health Organization, a Switzerland-based Intergovernmental organization reported that The WHO warns that fewer than one in three countries have a national policy to tackle neurological disorders, which cause over 11 million deaths annually. Additionally, its new report shows these conditions affect over 3 billion people,more than 40% of the global population. Therefore, the rising cases of brain disorders drive the growth of the intracranial hemorrhage devices market.
Leading companies in the intracranial hemorrhage devices market are focused on creating innovative products, such as advanced neuro access devices, to improve the precision and efficiency of diagnosing and treating brain injuries. These devices are specialized tools and technologies designed to provide accurate access to the brain or nervous system for diagnostic, surgical, or therapeutic purposes. For instance, in June 2024, Penumbra Inc., a medical device company based in the US, launched its advanced neuro access devices, BMX81 and BMX96, in Europe. These devices, designed for managing ischemic and hemorrhagic strokes, use advanced laser-cut stainless steel hypotube technology to enhance stability and trackability while allowing for larger inner diameters. This launch underscores Penumbra's dedication to improving stroke care in Europe.
In September 2024, Stryker Corporation, a US-based medical company, acquired NICO Corporation for an undisclosed amount. The acquisition aims to strengthen Stryker's neurotechnology capabilities in tumor and stroke care, as well as expand its portfolio of solutions for tumor resection and the treatment of intracerebral hemorrhage. NICO Corporation, a US-based medical equipment manufacturer, specializes in devices for treating intracranial hemorrhage (ICH).
Major companies operating in the intracranial hemorrhage devices market are Johnson & Johnson Services Inc., Medtronic Inc., Siemens Healthcare GmbH, Stryker Corporation, General Electric Company, Terumo Corporation, Canon Medical Systems Corporation, Penumbra Inc., MicroPort Scientific Corporation, Aidoc Medical Ltd., Viz.ai Inc., Phenox GmbH, RAPID AI Inc., Acandis GmbH, Kaneka Medix Corporation, Hyperfine Inc., ClearMind Biomedical Inc., InfraScan Inc., Schindler Endoskopie Technologie GmbH, Sense Neuro Diagnostics Inc., MaxQ AI Inc., Invamed Inc.
North America was the largest region in the intracranial hemorrhage devices market in 2025. The regions covered in the intracranial hemorrhage devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intracranial hemorrhage devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The intracranial hemorrhage devices market consists of sales of embolization devices, computed tomography scanners, balloon occlusion devices, and neuro-thrombectomy devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intracranial Hemorrhage Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intracranial hemorrhage devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intracranial hemorrhage devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intracranial hemorrhage devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.